ACIU vs BIIB: Which Stock is Better?
Side-by-side comparison of Ac Immune Sa and Biogen Inc in 2026
ACIU
Ac Immune Sa
$3.32
BIIB
Biogen Inc
$165.38
Key Metrics Comparison
| Metric | ACIU | BIIB | Winner |
|---|---|---|---|
| Market Cap | $353.11M | $24.26B | BIIB |
| P/E Ratio | N/A | 15.09 | BIIB |
| EPS (TTM) | $N/A | $10.96 | BIIB |
| Revenue Growth | -1.0% | 0.0% | BIIB |
| Gross Margin | -1308.9% | 76.6% | BIIB |
Analyze ACIU
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACIU or BIIB a better investment?
Comparing ACIU and BIIB: Ac Immune Sa has a market cap of $353.11M while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACIU and BIIB?
ACIU (Ac Immune Sa) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACIU or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACIU or BIIB?
BIIB has higher revenue growth at 0.0% vs -1.0% for ACIU.
Which company is more profitable: ACIU or BIIB?
Biogen Inc (BIIB) has higher gross margins at 76.6% compared to -1308.9% for ACIU.
Which is the larger company: ACIU or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $353.11M for ACIU.
Should I buy ACIU or BIIB in 2026?
Both ACIU and BIIB have investment merit. ACIU trades at $3.32 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACIU and BIIB stock?
Key differences: Market Cap ($353.11M vs $24.26B), P/E Ratio (N/A vs 15.1x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-1308.9% vs 76.6%).